Groove Botanicals (Groove Botanicals) Other Income (Expense) : $0.00 Mil (TTM As of Sep. 2023)

View and export this data going back to 1994. Start your Free Trial

What is Groove Botanicals Other Income (Expense)?

Groove Botanicals's other income expense for the Groove Botanicals's pretax income for the six months ended in Sep. 2023 was $0.00 Mil. Its other income expense for the trailing twelve months (TTM) ended in Sep. 2023 was $0.00 Mil.

Groove Botanicals Other Income (Expense) Historical Data

The historical data trend for Groove Botanicals's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Groove Botanicals Other Income (Expense) Chart

Groove Botanicals Annual Data

Trend

Mar08

Mar09

Mar10

Mar11

Mar12

Mar13

Mar14

Mar15

Mar16

Mar17

Other Income (Expense)

Get a 7-Day Free Trial

-0.05

0.52

-1.62

-0.02

Groove Botanicals Semi-Annual Data
	Mar09	Sep09	Mar10	Sep10	Mar11	Sep11	Mar12	Sep12	Mar13	Sep13	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Sep22	Sep23
Other Income (Expense)	Get a 7-Day Free Trial															-	-0.02	-	0.08	-

Groove Botanicals Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

Groove Botanicals (OTCPK:GRVE) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.